METTL14 and glioma: Remarkably, METTL14 inhibition enhances the efficacy of oncolytic HSV-1 (oHSV-1) in glioma, suggesting that the METTL14–ISG15 axis is both a viral immune checkpoint and a therapeutic target to potentiate oHSV-1 antitumor activity.